TY - JOUR
AU - H. Ashdown
AU - M. Smith
AU - E. McFadden
AU - I. Pavord
AU - C. Butler
AU - M. Bafadhel
AD - Nuffield Dept of Primary Care Sciences, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Nuffield Dept of Medicine, University of Oxford, Oxford, UK.
AN - 35141324
BT - ERJ Open Res
C2 - PMC8819252 National Institute for Health Research; and consulting fees and payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events received from Boehringer Ingelheim, outside the submitted work. M. Bafadhel reports grants or contracts from AZ; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from AZ, GSK, Chiesi, Cipla and Roche; participation on a Data Safety Monitoring Board or Advisory Board for AZ and GSK; and stock or stock options held for Albus Health; all outside the submitted work. I.D. Pavord reports support from Sanofi and Regeneron Pharmaceuticals, Inc., and nonfinancial support from Excerpta Medica, during the conduct of the study; and other support from Aerocrine AB, Almirall, AstraZeneca and Boehringer Ingelheim, grants and other support from Chiesi, other support from GSK, Novartis, Regeneron Pharmaceuticals, Inc., Sanofi, Teva, Circassia, Dey Pharma, Genentech, Knopp Biosciences, Merck, MSD, Napp Pharmaceuticals, RespiVert and Schering-Plough, outside the submitted work. The remaining authors have nothing to disclose.
DO - 10.1183/23120541.00606-2021
DP - NLM
ET - 2022/02/11
LA - eng
M1 - 1
N1 - 2312-0541
Ashdown, Helen F
Orcid: 0000-0002-7758-7095
Smith, Margaret
McFadden, Emily
Pavord, Ian D
Butler, Chris C
Bafadhel, Mona
Orcid: 0000-0002-9993-2478
Journal Article
ERJ Open Res. 2021 Feb 7;8(1):00606-2021. doi: 10.1183/23120541.00606-2021. eCollection 2022 Jan.
PY - 2022
SN - 2312-0541 (Print)
2312-0541
T2 - ERJ Open Res
TI - Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
VL - 8
ER -